Michael Risk

1.5k total citations
44 papers, 1.1k citations indexed

About

Michael Risk is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael Risk has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Michael Risk's work include Prostate Cancer Treatment and Research (12 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Michael Risk is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). Michael Risk collaborates with scholars based in United States, South Korea and Germany. Michael Risk's co-authors include Peter S. Nelson, Ilsa M. Coleman, Lawrence D. True, Philipp Dahm, Valeri Vasioukhin, Jared M. Lucas, Olga Klezovitch, Daniel W. Lin, David Campbell and Eric W. Deutsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Michael Risk

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Risk United States 16 471 445 228 166 145 44 1.1k
Shino Murakami Japan 14 349 0.7× 589 1.3× 216 0.9× 130 0.8× 213 1.5× 63 1.2k
Shengsong Huang China 20 183 0.4× 456 1.0× 73 0.3× 72 0.4× 283 2.0× 51 926
Valerié Schumacher Germany 24 284 0.6× 1.4k 3.2× 210 0.9× 82 0.5× 137 0.9× 36 1.8k
Merja Bläuer Finland 23 238 0.5× 489 1.1× 334 1.5× 252 1.5× 252 1.7× 61 1.6k
Hsiang‐Ying Lee Taiwan 18 130 0.3× 728 1.6× 129 0.6× 137 0.8× 110 0.8× 33 1.1k
Toshifumi Kawakami Japan 16 194 0.4× 1.1k 2.4× 196 0.9× 330 2.0× 260 1.8× 31 1.6k
Sanjeevkumar R. Patel United States 23 226 0.5× 1.2k 2.7× 168 0.7× 265 1.6× 79 0.5× 42 1.9k
Xiangming Mao China 21 148 0.3× 811 1.8× 127 0.6× 74 0.4× 630 4.3× 82 1.3k
Chengliu Jin United States 23 203 0.4× 1.3k 2.9× 273 1.2× 307 1.8× 208 1.4× 32 1.8k
Ricardo Ribeiro Portugal 23 417 0.9× 535 1.2× 112 0.5× 365 2.2× 413 2.8× 64 1.5k

Countries citing papers authored by Michael Risk

Since Specialization
Citations

This map shows the geographic impact of Michael Risk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Risk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Risk more than expected).

Fields of papers citing papers by Michael Risk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Risk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Risk. The network helps show where Michael Risk may publish in the future.

Co-authorship network of co-authors of Michael Risk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Risk. A scholar is included among the top collaborators of Michael Risk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Risk. Michael Risk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Parikshit, E. Jason Abel, Joshua D. Mezrich, et al.. (2025). Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation. Urology. 209. 81–86.
2.
Das, Arighno, Michael Risk, Daniel D. Shapiro, et al.. (2023). Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion. Urology. 184. 272–277. 1 indexed citations
3.
Risk, Michael, et al.. (2023). Unique Presentation and Perioperative Management of a Giant Pheochromocytoma. JCEM Case Reports. 1(3). luad065–luad065.
4.
Uhlig, Annemarie, et al.. (2020). Cytoreductive nephrectomy in metastatic renal cell carcinoma. Cochrane Database of Systematic Reviews. 1 indexed citations
5.
Sathianathen, Niranjan, Michael Risk, & Badrinath R. Konety. (2018). Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urologic Clinics of North America. 45(2). 215–228. 3 indexed citations
6.
7.
Hwang, Eu Chang, Niranjan Sathianathen, Jae Hung Jung, et al.. (2018). Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma. Cochrane Database of Systematic Reviews. 20 indexed citations
8.
9.
Dahm, Philipp, Michelle Brasure, Roderick MacDonald, et al.. (2016). Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis. European Urology. 71(4). 570–581. 55 indexed citations
10.
Warlick, Christopher A., et al.. (2015). Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation. Prostate Cancer and Prostatic Diseases. 18(3). 255–259. 24 indexed citations
11.
Isharwal, Sumit & Michael Risk. (2014). Management of clinical stage I nonseminomatous germ cell tumors. Expert Review of Anticancer Therapy. 14(9). 1021–1032. 7 indexed citations
12.
Brincks, Erik L., Michael Risk, & Thomas S. Griffith. (2013). PMN and anti-tumor immunity—The case of bladder cancer immunotherapy. Seminars in Cancer Biology. 23(3). 183–189. 34 indexed citations
13.
Liu, Nick, Michael Risk, Virgilio George, Bruce W. Robb, & Thomas A. Gardner. (2012). Incisionless Dual Diversions: Creation of Urostomy and Colostomy Using the Da Vinci Robot. Videourology. 26(4). 2 indexed citations
14.
Risk, Michael, Beatrice S. Knudsen, Ilsa M. Coleman, et al.. (2010). Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect. Clinical Cancer Research. 16(22). 5414–5423. 43 indexed citations
15.
Risk, Michael & Richard S. Foster. (2010). Postchemotherapy retroperitoneal lymph node dissection for testis cancer. Expert Review of Anticancer Therapy. 11(1). 95–106. 2 indexed citations
16.
Vemulakonda, Vijaya M., Martin A. Koyle, Thomas S. Lendvay, et al.. (2009). Endoscopic treatment of symptomatic refluxing renal transplant ureteroneocystostomies in children. Pediatric Transplantation. 14(2). 212–215. 13 indexed citations
17.
Risk, Michael & Christopher R. Porter. (2009). Management of non-germinal testicular tumors. World Journal of Urology. 27(4). 507–512. 6 indexed citations
18.
Risk, Michael & Daniel W. Lin. (2009). New and novel markers for prostate cancer detection. Current Urology Reports. 10(3). 179–186. 7 indexed citations
19.
Pascal, Laura E., Lawrence D. True, David Campbell, et al.. (2008). Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics. 9(1). 246–246. 209 indexed citations
20.
Sugino, Norihiro, R. K. Srivastava, Carlos Telleria, et al.. (1998). Establishment and Characterization of a Simian Virus 40-Transformed Temperature-Sensitive Rat Luteal Cell Line1. Endocrinology. 139(4). 1936–1942. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shino Murakami Breakdown of academic impact, for papers by Shengsong Huang Breakdown of academic impact, for papers by Valerié Schumacher Breakdown of academic impact, for papers by Merja Bläuer Breakdown of academic impact, for papers by Hsiang‐Ying Lee Breakdown of academic impact, for papers by Toshifumi Kawakami Breakdown of academic impact, for papers by Sanjeevkumar R. Patel Breakdown of academic impact, for papers by Xiangming Mao Breakdown of academic impact, for papers by Chengliu Jin Breakdown of academic impact, for papers by Ricardo Ribeiro
Rankless by CCL
2026